EZH2 and prostate cancer: To confirm previous findings, we analyzed the microarray data of GSE21032, GSE16560, and GSE35988, and found that the EZH2 mRNA levels in metastatic prostate cancer samples were much higher compared with those of the nonmetastatic prostate cancer samples and the paired normal tissues.